CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?

by Ana Maria Oliveira Battastini, Fabricio Figueiró, Fabricio Figueiró, Daniela Bitencourt Rosa Leal, Pedro Henrique Doleski, Maria Rosa Chitolina Schetinger
Published 2021-03-01

Exosomes: Small EVs with Large Immunomodulatory Effect in Glioblastoma

by Laura Benecke, Mali Coray, Sandra Umbricht, Dapi Chiang, Fabrício Figueiró, Laurent Muller
Published 2021-03-01

Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells

by José Ignácio Gonzalez Solari, Eduardo Filippi-Chiela, Emily Salles Pilar, Vitória Nunes, Esteban Alberto Gonzalez, Fabrício Figueiró, Cristiano Feijó Andrade, Fábio Klamt
Published 2020-05-01

Ecto-5'-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma Model.

by Angélica R Cappellari, Micheli M Pillat, Hellio D N Souza, Fabrícia Dietrich, Francine H Oliveira, Fabrício Figueiró, Ana L Abujamra, Rafael Roesler, Joanna Lecka, Jean Sévigny, Ana Maria O Battastini, Henning Ulrich
Published 2015-01-01

Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane

by Danieli Rosane Dallemole, Thatiana Terroso, Aline de Cristo Soares Alves, Juliete Nathali Scholl, Giovana Ravizzoni Onzi, Rodrigo Cé, Karina Paese, Ana Maria Oliveira Battastini, Silvia Stanisçuaski Guterres, Fabrício Figueiró, Adriana Raffin Pohlmann
Published 2021-06-01